Hims & Hers CEO Andrew Dudum said in a post on X yesterday that the company would continue to monitor supply constraints, but will still offer personalized treatments as allowed by law to meet patient needs. Expect more lawsuits
Last reviewed: May 29, 2026
Choice of additional antihyperglycemic agents, when treatment intensification is required to improve glycemia, should consider individual priorities, preferences, and comorbidities
Yes, again, even though you cleaned it during reconstitution
Studies on the role of further protein kinases in eryptosis are solely based on cell culture experiments and pharmacological evidence: Activation of serine/threonine-protein kinase C (PKC) induces eryptosis (Fig
And now, were digging into the data to learn even more, so we can continue to expand access and make this process easier for everyone